RENELEF Trademark

Trademark Overview


On Friday, December 12, 2008, a trademark application was filed for RENELEF with the United States Patent and Trademark Office. The USPTO has given the RENELEF trademark a serial number of 77632021. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, March 14, 2012. This trademark is owned by Pfizer Inc.. The RENELEF trademark is filed in the Pharmaceutical Products category with the following description:

Veterinary pharmaceutical preparations and substances for the prevention and treatment of parasitic infections, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal diseases, osteoporosis, cardiovascular disease, central nervous system diseases and disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, stroke, cancer, blood, pain, obesity, digestive disorders, ophthalmological disorders, behavioral disorders, reproductive disorders, dermatological disorders, tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease and for skin and tissue repair and to lower cholesterol; nutritional additives and food supplements for medical purposes; all of the foregoing for treating felines, canines, bovines, porcines, equines, llamas, rabbits, rodents, birds, ferrets, poultry, goats and sheep
renelef

General Information


Serial Number77632021
Word MarkRENELEF
Filing DateFriday, December 12, 2008
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, March 14, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2009

Trademark Statements


Goods and ServicesVeterinary pharmaceutical preparations and substances for the prevention and treatment of parasitic infections, inflammation and inflammatory diseases, respiratory and infectious diseases, immunological, bacterial, viral and fungal diseases, osteoporosis, cardiovascular disease, central nervous system diseases and disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, stroke, cancer, blood, pain, obesity, digestive disorders, ophthalmological disorders, behavioral disorders, reproductive disorders, dermatological disorders, tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease and for skin and tissue repair and to lower cholesterol; nutritional additives and food supplements for medical purposes; all of the foregoing for treating felines, canines, bovines, porcines, equines, llamas, rabbits, rodents, birds, ferrets, poultry, goats and sheep

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, March 14, 2012
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Wednesday, March 14, 2012ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Wednesday, March 14, 2012ABANDONMENT - AFTER PUBLICATION
Tuesday, March 13, 2012TEAS EXPRESS ABANDONMENT RECEIVED
Saturday, January 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 13, 2012EXTENSION 5 GRANTED
Monday, January 9, 2012EXTENSION 5 FILED
Monday, January 9, 2012TEAS EXTENSION RECEIVED
Friday, July 29, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 28, 2011EXTENSION 4 GRANTED
Wednesday, July 20, 2011EXTENSION 4 FILED
Wednesday, July 20, 2011TEAS EXTENSION RECEIVED
Friday, January 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 20, 2011EXTENSION 3 GRANTED
Tuesday, January 18, 2011EXTENSION 3 FILED
Tuesday, January 18, 2011TEAS EXTENSION RECEIVED
Friday, June 18, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 17, 2010EXTENSION 2 GRANTED
Wednesday, June 9, 2010EXTENSION 2 FILED
Wednesday, June 9, 2010TEAS EXTENSION RECEIVED
Friday, February 12, 2010EXTENSION 1 GRANTED
Tuesday, January 5, 2010EXTENSION 1 FILED
Monday, February 8, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 5, 2010TEAS EXTENSION RECEIVED
Tuesday, July 21, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2009NOTICE OF PUBLICATION
Monday, March 23, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 23, 2009ASSIGNED TO LIE
Monday, March 23, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 9, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 9, 2009NON-FINAL ACTION E-MAILED
Monday, March 9, 2009NON-FINAL ACTION WRITTEN
Saturday, March 7, 2009ASSIGNED TO EXAMINER
Tuesday, December 16, 2008NEW APPLICATION ENTERED IN TRAM